Marks Group Wealth Management, Inc Astrazeneca PLC Transaction History
Marks Group Wealth Management, Inc
- $1.03 Billion
- Q3 2025
A detailed history of Marks Group Wealth Management, Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Marks Group Wealth Management, Inc holds 34,450 shares of AZN stock, worth $3.08 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
34,450
Previous 28,554
20.65%
Holding current value
$3.08 Million
Previous $2 Million
32.48%
% of portfolio
0.26%
Previous 0.19%
Shares
9 transactions
Others Institutions Holding AZN
# of Institutions
1,507Shares Held
501MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...